Dr. Reddy's Laboratories launches Regadenoson Injection in U.S. market

05 May 2023 Evaluate

Dr. Reddy's Laboratories has launched Regadenoson Injection in the U.S. market, a generic therapeutic equivalent of Lexiscan (Regadenoson) injection, approved by U.S. Food and Drug Administration (USFDA). The company’s Regadenoson Injection is supplied as single-dose pre-filled syringes, 0.4 mg/5 mL (0.08 mg/mL).

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1318.00 18.60 (1.43%)
25-Feb-2026 12:39 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1763.40
Dr. Reddys Lab 1318.00
Cipla 1340.00
Zydus Lifesciences 915.55
Lupin 2292.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×